Contributors |
|
xix | |
Preface |
|
xxi | |
Introduction |
|
xxiii | |
|
Hypothalamic-Pituitary Disease |
|
|
1 | (38) |
|
|
|
|
|
Evaluation of the Hypothalamic-Pituitary Axis |
|
|
1 | (3) |
|
|
1 | (1) |
|
|
1 | (1) |
|
|
2 | (1) |
|
|
2 | (1) |
|
|
2 | (1) |
|
|
3 | (1) |
|
|
3 | (1) |
|
|
3 | (1) |
|
|
3 | (1) |
|
Adrenocorticotropic Hormone |
|
|
3 | (1) |
|
|
3 | (1) |
|
|
4 | (1) |
|
|
4 | (1) |
|
|
4 | (1) |
|
Imaging of the Hypothalamic-Pituitary System |
|
|
4 | (1) |
|
Radiologic Imaging Techniques |
|
|
4 | (1) |
|
|
5 | (1) |
|
|
5 | (4) |
|
|
5 | (1) |
|
|
6 | (1) |
|
|
6 | (1) |
|
|
6 | (1) |
|
|
6 | (1) |
|
|
7 | (1) |
|
|
8 | (1) |
|
|
9 | (6) |
|
|
9 | (1) |
|
|
9 | (1) |
|
Classification and Clinical Findings |
|
|
9 | (1) |
|
|
10 | (3) |
|
|
13 | (1) |
|
|
13 | (1) |
|
|
14 | (1) |
|
|
14 | (1) |
|
|
15 | (1) |
|
|
15 | (1) |
|
|
15 | (1) |
|
Disorders of the Prolactin System |
|
|
15 | (2) |
|
|
15 | (1) |
|
|
15 | (1) |
|
|
16 | (1) |
|
|
16 | (1) |
|
|
17 | (1) |
|
Pregnancy and Hyperprolactinemia |
|
|
17 | (1) |
|
|
17 | (3) |
|
|
18 | (1) |
|
|
18 | (1) |
|
Pathophysiology and Clinical Presentation |
|
|
18 | (1) |
|
|
18 | (1) |
|
|
19 | (1) |
|
|
19 | (1) |
|
|
19 | (1) |
|
|
19 | (1) |
|
|
20 | (1) |
|
|
20 | (1) |
|
|
20 | (3) |
|
Etiology and Pathogenesis |
|
|
20 | (1) |
|
|
20 | (1) |
|
|
20 | (1) |
|
|
20 | (1) |
|
|
21 | (1) |
|
|
21 | (1) |
|
|
21 | (1) |
|
Central Diabetes Insipidus |
|
|
21 | (1) |
|
Nephrogenic Diabetes Insipidus |
|
|
22 | (1) |
|
|
22 | (1) |
|
|
22 | (1) |
|
|
23 | (1) |
|
Central Diabetes Insipidus |
|
|
23 | (1) |
|
Nephrogenic Diabetes Insipidus |
|
|
23 | (1) |
|
Syndrome of Inappropriate Antidiuretic Hormone Secretion |
|
|
23 | (16) |
|
|
23 | (1) |
|
|
24 | (1) |
|
|
24 | (1) |
|
|
25 | (1) |
|
|
25 | (1) |
|
|
25 | (1) |
|
|
25 | (1) |
|
|
25 | (1) |
|
|
26 | (1) |
|
|
26 | (13) |
|
|
39 | (36) |
|
|
|
Evaluation of Thyroid Function |
|
|
39 | (2) |
|
|
39 | (1) |
|
|
40 | (1) |
|
Total Thyroxine and Triiodothyronine |
|
|
40 | (1) |
|
|
40 | (1) |
|
|
41 | (1) |
|
|
41 | (2) |
|
|
41 | (1) |
|
|
42 | (1) |
|
|
42 | (1) |
|
|
42 | (1) |
|
|
42 | (1) |
|
18F-Fluorodeoxyglucose Positron Emission Tomography |
|
|
43 | (1) |
|
|
43 | (4) |
|
|
43 | (1) |
|
|
43 | (1) |
|
|
44 | (1) |
|
|
44 | (1) |
|
|
44 | (2) |
|
|
46 | (1) |
|
|
46 | (1) |
|
Antithyroid Drugs Plus LT4 |
|
|
46 | (1) |
|
|
46 | (1) |
|
|
47 | (1) |
|
|
47 | (1) |
|
|
47 | (1) |
|
|
47 | (1) |
|
|
47 | (1) |
|
Epidemiology and Pathophysiology |
|
|
48 | (1) |
|
|
48 | (1) |
|
|
48 | (1) |
|
|
48 | (1) |
|
|
48 | (2) |
|
|
48 | (1) |
|
|
49 | (1) |
|
|
49 | (1) |
|
|
49 | (1) |
|
|
49 | (1) |
|
Suppressive Therapy With Levothyroxine |
|
|
50 | (1) |
|
|
50 | (1) |
|
Percutaneous Ethanol Injection |
|
|
50 | (1) |
|
|
50 | (4) |
|
Definition and Classification |
|
|
50 | (1) |
|
|
51 | (1) |
|
|
51 | (1) |
|
Fine-Needle Aspiration Biopsy |
|
|
51 | (1) |
|
|
51 | (1) |
|
|
52 | (1) |
|
|
52 | (1) |
|
|
52 | (1) |
|
|
53 | (1) |
|
Thyroid Hormone Suppression of TSH |
|
|
53 | (1) |
|
|
54 | (21) |
|
|
54 | (1) |
|
|
54 | (1) |
|
|
54 | (1) |
|
|
54 | (1) |
|
Triiodothyronine Replacement |
|
|
54 | (21) |
|
|
75 | (34) |
|
|
|
|
Evaluation of Adrenocortical Function |
|
|
75 | (1) |
|
Evaluation of Glucocorticoid Disorders |
|
|
75 | (1) |
|
Evaluation of Mineralocorticoid Disorders |
|
|
75 | (1) |
|
Evaluation of Adrenal Androgen Production and Congenital Adrenal Hyperplasia |
|
|
76 | (1) |
|
|
76 | (3) |
|
Computed Tomography Scanning |
|
|
76 | (1) |
|
Magnetic Resonance Imaging |
|
|
77 | (1) |
|
Adrenal Cortical Scintigraphy |
|
|
77 | (1) |
|
Adrenal Medullary Scintigraphy |
|
|
78 | (1) |
|
Adrenal Venography and Sampling |
|
|
78 | (1) |
|
Primary Hyperaldosteronism |
|
|
79 | (3) |
|
|
79 | (1) |
|
|
79 | (1) |
|
|
79 | (1) |
|
|
80 | (2) |
|
|
82 | (1) |
|
|
82 | (4) |
|
Etiology and Pathogenesis |
|
|
82 | (1) |
|
|
83 | (1) |
|
|
83 | (1) |
|
|
83 | (2) |
|
|
85 | (1) |
|
|
85 | (1) |
|
|
85 | (1) |
|
|
86 | (2) |
|
|
86 | (1) |
|
Etiology and Epidemiology |
|
|
86 | (1) |
|
|
86 | (1) |
|
|
87 | (1) |
|
|
88 | (4) |
|
|
88 | (1) |
|
Etiology and Epidemiology |
|
|
88 | (1) |
|
|
88 | (1) |
|
|
88 | (1) |
|
Decreased Cortisol Production |
|
|
89 | (1) |
|
Response to Exogenous ACTH (Cosyntropin) Stimulation |
|
|
90 | (1) |
|
|
91 | (1) |
|
Plasma Renin Activity and Aldosterone |
|
|
91 | (1) |
|
|
91 | (1) |
|
Insulin Hypoglycemia Test |
|
|
91 | (1) |
|
Corticotropin-Releasing Hormone Test |
|
|
91 | (1) |
|
|
91 | (1) |
|
|
91 | (1) |
|
|
92 | (17) |
|
|
92 | (1) |
|
|
92 | (1) |
|
|
93 | (1) |
|
|
94 | (1) |
|
|
94 | (15) |
|
|
109 | (48) |
|
|
Evaluation of Metabolic Bone Disorders |
|
|
109 | (2) |
|
Serum Calcium, Phosphorus, and Magnesium |
|
|
109 | (1) |
|
Intact Parathyroid Hormone |
|
|
109 | (1) |
|
|
109 | (1) |
|
Parathyroid Hormone-Related Protein |
|
|
110 | (1) |
|
|
110 | (1) |
|
Urinary Calcium Excretion |
|
|
110 | (1) |
|
Biochemical Markers of Bone Turnover |
|
|
110 | (1) |
|
|
110 | (1) |
|
|
110 | (1) |
|
|
110 | (1) |
|
|
111 | (1) |
|
|
111 | (1) |
|
|
112 | (1) |
|
|
112 | (1) |
|
|
112 | (1) |
|
|
112 | (8) |
|
|
112 | (1) |
|
|
113 | (1) |
|
|
113 | (1) |
|
|
113 | (1) |
|
|
114 | (1) |
|
|
114 | (3) |
|
|
117 | (1) |
|
|
117 | (1) |
|
Hormone Replacement Therapy |
|
|
117 | (1) |
|
|
118 | (1) |
|
|
118 | (1) |
|
Calcium and Vitamin D Supplementation |
|
|
119 | (1) |
|
|
119 | (1) |
|
|
119 | (1) |
|
|
119 | (1) |
|
|
120 | (3) |
|
|
120 | (1) |
|
|
120 | (1) |
|
|
120 | (1) |
|
|
120 | (1) |
|
|
121 | (1) |
|
|
122 | (1) |
|
|
122 | (1) |
|
|
122 | (1) |
|
Primary Hyperparathyroidism |
|
|
123 | (3) |
|
|
123 | (1) |
|
|
124 | (1) |
|
|
124 | (1) |
|
|
125 | (1) |
|
|
125 | (1) |
|
|
126 | (1) |
|
|
126 | (5) |
|
|
127 | (2) |
|
|
129 | (1) |
|
|
129 | (1) |
|
Decrease Intestinal Absorption |
|
|
129 | (1) |
|
Increase Urinary Calcium Excretion |
|
|
129 | (1) |
|
|
129 | (1) |
|
|
130 | (1) |
|
|
130 | (1) |
|
|
131 | (1) |
|
|
131 | (2) |
|
|
131 | (1) |
|
|
132 | (1) |
|
|
132 | (1) |
|
|
132 | (1) |
|
|
133 | (1) |
|
|
133 | (1) |
|
|
133 | (24) |
|
Vitamin D Deficiency in Adults |
|
|
133 | (1) |
|
Vitamin D--Dependent Rickets (Type 1 and Type 2) |
|
|
134 | (1) |
|
|
134 | (1) |
|
|
135 | (1) |
|
|
135 | (1) |
|
Drug-Induced Osteomalacia |
|
|
135 | (22) |
|
|
157 | (28) |
|
|
|
157 | (4) |
|
|
157 | (1) |
|
|
157 | (1) |
|
|
157 | (1) |
|
|
157 | (3) |
|
|
160 | (1) |
|
|
161 | (2) |
|
Definition and Pathophysiology |
|
|
161 | (1) |
|
|
161 | (1) |
|
|
162 | (1) |
|
|
162 | (1) |
|
|
162 | (1) |
|
|
163 | (3) |
|
|
163 | (1) |
|
|
164 | (1) |
|
|
164 | (1) |
|
|
165 | (1) |
|
|
166 | (1) |
|
|
166 | (1) |
|
|
166 | (1) |
|
|
166 | (1) |
|
|
167 | (4) |
|
|
167 | (1) |
|
|
167 | (3) |
|
|
170 | (1) |
|
|
170 | (1) |
|
|
171 | (14) |
|
|
171 | (1) |
|
|
171 | (1) |
|
|
171 | (14) |
|
|
185 | (52) |
|
|
|
185 | (7) |
|
|
185 | (1) |
|
|
185 | (1) |
|
|
185 | (1) |
|
Major Histocompatibility Complex Genes |
|
|
185 | (1) |
|
|
186 | (1) |
|
|
186 | (1) |
|
|
187 | (1) |
|
|
187 | (1) |
|
|
187 | (1) |
|
|
188 | (1) |
|
|
188 | (1) |
|
|
188 | (1) |
|
|
189 | (1) |
|
|
189 | (2) |
|
|
191 | (1) |
|
|
191 | (1) |
|
|
192 | (1) |
|
|
192 | (1) |
|
|
192 | (6) |
|
|
192 | (1) |
|
|
192 | (1) |
|
|
192 | (1) |
|
|
193 | (1) |
|
|
194 | (1) |
|
|
194 | (1) |
|
|
194 | (1) |
|
|
194 | (1) |
|
|
195 | (1) |
|
|
195 | (1) |
|
|
195 | (1) |
|
Weight Reduction and Dietary Restrictions |
|
|
195 | (1) |
|
|
196 | (1) |
|
|
196 | (1) |
|
|
197 | (1) |
|
|
197 | (1) |
|
|
197 | (1) |
|
|
198 | (3) |
|
|
198 | (1) |
|
|
198 | (1) |
|
|
198 | (1) |
|
|
198 | (1) |
|
|
198 | (1) |
|
|
199 | (1) |
|
|
199 | (1) |
|
|
199 | (1) |
|
|
199 | (1) |
|
|
200 | (1) |
|
|
200 | (1) |
|
|
200 | (1) |
|
|
201 | (1) |
|
|
201 | (2) |
|
|
201 | (1) |
|
|
201 | (1) |
|
|
201 | (1) |
|
|
201 | (1) |
|
|
202 | (1) |
|
|
202 | (1) |
|
|
202 | (1) |
|
|
202 | (1) |
|
|
202 | (1) |
|
|
202 | (1) |
|
|
203 | (1) |
|
|
203 | (3) |
|
|
203 | (1) |
|
|
203 | (1) |
|
|
203 | (1) |
|
|
204 | (1) |
|
|
204 | (1) |
|
|
204 | (1) |
|
|
204 | (1) |
|
|
204 | (1) |
|
|
205 | (1) |
|
|
205 | (1) |
|
|
205 | (1) |
|
|
206 | (1) |
|
|
206 | (1) |
|
Complications of Diabetes |
|
|
206 | (31) |
|
|
206 | (1) |
|
|
206 | (1) |
|
|
206 | (1) |
|
|
207 | (1) |
|
|
207 | (2) |
|
|
209 | (1) |
|
|
209 | (1) |
|
|
210 | (1) |
|
|
210 | (1) |
|
|
210 | (1) |
|
|
210 | (2) |
|
|
212 | (1) |
|
|
212 | (1) |
|
|
212 | (1) |
|
|
212 | (1) |
|
|
212 | (1) |
|
|
213 | (1) |
|
|
213 | (1) |
|
|
213 | (1) |
|
|
213 | (1) |
|
|
214 | (1) |
|
|
214 | (1) |
|
|
214 | (1) |
|
|
215 | (22) |
|
Lipid Disorders and Obesity |
|
|
237 | (20) |
|
|
|
237 | (5) |
|
|
237 | (1) |
|
|
237 | (1) |
|
|
237 | (1) |
|
|
238 | (1) |
|
|
238 | (1) |
|
|
238 | (1) |
|
|
239 | (1) |
|
|
239 | (1) |
|
|
239 | (1) |
|
|
240 | (1) |
|
|
240 | (1) |
|
|
240 | (1) |
|
|
240 | (1) |
|
|
241 | (1) |
|
|
242 | (15) |
|
|
242 | (1) |
|
|
243 | (1) |
|
|
243 | (1) |
|
|
244 | (1) |
|
|
244 | (1) |
|
|
244 | (1) |
|
|
245 | (1) |
|
|
245 | (1) |
|
|
245 | (1) |
|
|
246 | (11) |
|
Unusual Endocrine Malignancies |
|
|
257 | (44) |
|
|
|
|
|
Multiple Endocrine Neoplasia |
|
|
257 | (12) |
|
|
257 | (1) |
|
|
257 | (2) |
|
|
259 | (1) |
|
Multiple Endocrine Neoplasia Type 1 |
|
|
259 | (1) |
|
|
260 | (1) |
|
|
260 | (1) |
|
|
261 | (1) |
|
Insulin-Secreting and Other Tumor Types |
|
|
262 | (1) |
|
|
263 | (1) |
|
|
263 | (1) |
|
|
264 | (1) |
|
Multiple Endocrine Neoplasia Type 2 |
|
|
264 | (1) |
|
|
265 | (1) |
|
Medullary Thyroid Carcinoma |
|
|
266 | (1) |
|
|
267 | (1) |
|
|
268 | (1) |
|
Paraneoplastic Endocrine Syndromes |
|
|
269 | (7) |
|
Hypercalcemia of Malignancy |
|
|
269 | (1) |
|
|
269 | (3) |
|
|
272 | (1) |
|
|
273 | (1) |
|
|
273 | (1) |
|
|
274 | (1) |
|
|
275 | (1) |
|
|
275 | (1) |
|
Bisphosphonates and Bone Metastases |
|
|
276 | (1) |
|
|
276 | (25) |
|
|
276 | (1) |
|
|
276 | (1) |
|
|
277 | (1) |
|
|
277 | (1) |
|
|
278 | (1) |
|
|
279 | (22) |
Index |
|
301 | |